Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines

被引:21
作者
Abbasi, Saed [1 ]
Uchida, Satoshi [1 ,2 ]
机构
[1] Kawasaki Inst Ind Promot, Innovat Ctr NanoMed, Kawasaki Ku, 3-25-14 Tonomachi, Kawasaki, Kanagawa 2100821, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Med Chem, Sakyo Ku, 1-5 Shimogamohangi Cho, Kyoto 6060823, Japan
基金
日本学术振兴会;
关键词
pDNA; mRNA; subunit vaccine; adjuvant; nonviral vaccine; DOUBLE-STRANDED-RNA; MONOPHOSPHORYL-LIPID-A; MODIFIED MESSENGER-RNA; T-CELL RESPONSES; INNATE IMMUNE-RESPONSE; PLASMID DNA; IN-VIVO; DRUG-DELIVERY; ANTIGEN PRESENTATION; DEXTRAN SULFATE;
D O I
10.3390/pharmaceutics13050644
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Subunit vaccines based on antigen-encoding nucleic acids have shown great promise for antigen-specific immunization against cancer and infectious diseases. Vaccines require immunostimulatory adjuvants to activate the innate immune system and trigger specific adaptive immune responses. However, the incorporation of immunoadjuvants into nonviral nucleic acid delivery systems often results in fairly complex structures that are difficult to mass-produce and characterize. In recent years, minimalist approaches have emerged to reduce the number of components used in vaccines. In these approaches, delivery materials, such as lipids and polymers, and/or pDNA/mRNA are designed to simultaneously possess several functionalities of immunostimulatory adjuvants. Such multifunctional immunoadjuvants encode antigens, encapsulate nucleic acids, and control their pharmacokinetic or cellular fate. Herein, we review a diverse class of multifunctional immunoadjuvants in nucleic acid subunit vaccines and provide a detailed description of their mechanisms of adjuvanticity and induction of specific immune responses.
引用
收藏
页数:29
相关论文
共 241 条
[1]   In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide-Loaded Liposomes and Interleukin-12 [J].
Abdelmegeed, Heba ;
Nakamura, Takashi ;
Harashima, Hideyoshi .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (01) :250-256
[2]   Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose [J].
Abeyratne, Eranga ;
Tharmarajah, Kothila ;
Freitas, Joseph R. ;
Mostafavi, Helen ;
Mahalingam, Suresh ;
Zaid, Ali ;
Zaman, Mehfuz ;
Taylor, Adam .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[3]   Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].
Adams, D. ;
Gonzalez-Duarte, A. ;
O'Riordan, W. D. ;
Yang, C. -C. ;
Ueda, M. ;
Kristen, A. V. ;
Tournev, I. ;
Schmidt, H. H. ;
Coelho, T. ;
Berk, J. L. ;
Lin, K. -P. ;
Vita, G. ;
Attarian, S. ;
Plante-Bordeneuve, V. ;
Mezei, M. M. ;
Campistol, J. M. ;
Buades, J. ;
Brannagan, T. H., III ;
Kim, B. J. ;
Oh, J. ;
Parman, Y. ;
Sekijima, Y. ;
Hawkins, P. N. ;
Solomon, S. D. ;
Polydefkis, M. ;
Dyck, P. J. ;
Gandhi, P. J. ;
Goyal, S. ;
Chen, J. ;
Strahs, A. L. ;
Nochur, S. V. ;
Sweetser, M. T. ;
Garg, P. P. ;
Vaishnaw, A. K. ;
Gollob, J. A. ;
Suhr, O. B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21
[4]   Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines;: immunity, pathology and protection [J].
Agger, Else Marie ;
Cassidy, Joseph P. ;
Brady, Joseph ;
Korsholm, Karen S. ;
Vingsbo-Lundberg, Carina ;
Andersen, Peter .
IMMUNOLOGY, 2008, 124 (02) :175-185
[5]   Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements [J].
Agger, Else Marie ;
Rosenkrands, Ida ;
Hansen, Jon ;
Brahimi, Karima ;
Vandahl, Brian S. ;
Aagaard, Claus ;
Werninghaus, Kerstin ;
Kirschning, Carsten ;
Lang, Roland ;
Christensen, Dennis ;
Theisen, Michael ;
Follmann, Frank ;
Andersen, Peter .
PLOS ONE, 2008, 3 (09)
[6]   The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs [J].
Akinc, Akin ;
Maier, Martin A. ;
Manoharan, Muthiah ;
Fitzgerald, Kevin ;
Jayaraman, Muthusamy ;
Barros, Scott ;
Ansell, Steven ;
Du, Xinyao ;
Hope, Michael J. ;
Madden, Thomas D. ;
Mui, Barbara L. ;
Semple, Sean C. ;
Tam, Ying K. ;
Ciufolini, Marco ;
Witzigmann, Dominik ;
Kulkarni, Jayesh A. ;
van der Meel, Roy ;
Cullis, Pieter R. .
NATURE NANOTECHNOLOGY, 2019, 14 (12) :1084-1087
[7]   Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial [J].
Alberer, Martin ;
Gnad-Vogt, Ulrike ;
Hong, Henoch Sangjoon ;
Mehr, Keyvan Tadjalli ;
Backert, Linus ;
Finak, Greg ;
Gottardo, Raphael ;
Bica, Mihai Alexandru ;
Garofano, Aurelio ;
Koch, Sven Dominik ;
Fotin-Mleczek, Mariola ;
Hoerr, Ingmar ;
Clemens, Ralf ;
von Sonnenburg, Frank .
LANCET, 2017, 390 (10101) :1511-1520
[8]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[9]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[10]  
Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]